Vista Pharmaceuticals is currently trading at Rs. 46.10, up by 0.95 points or 2.10% from its previous closing of Rs. 45.15 on the BSE.
The scrip opened at Rs. 46.95 and has touched a high and low of Rs. 47.20 and Rs. 44.55 respectively. So far 54848 shares were traded on the counter.
The BSE group 'XT' stock of face value Rs. 2 has touched a 52 week high of Rs. 47.95 on 17-Apr-2017 and a 52 week low of Rs. 12.56 on 07-Jun-2016.
Last one week high and low of the scrip stood at Rs. 47.30 and Rs. 42.75 respectively. The current market cap of the company is Rs. 123.55 crore.
The promoters holding in the company stood at 31.19%, while Institutions and Non-Institutions held 0.05% and 68.75% respectively.
Vista Pharmaceuticals has paid GDUFA (Generic Drug User Fee Amendments of 2012) Facility fees payable by the company to US Food & Drug Administration (USFDA). GDUFA is a law designed to speed access to safe and effective generic drugs to the public, and reduce costs to industry.
Vista Pharmaceuticals is engaged in manufacturing and selling of pharmaceutical, medical and veterinary preparations. The company also sells the products to its related companies, which are engaged in the manufacture of formulations.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1486.55 |
Dr. Reddys Lab | 5860.25 |
Cipla | 1482.55 |
Zydus Lifesciences | 1072.35 |
Lupin | 1613.65 |
View more.. |